CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GSK plc

GSK
$100.46BLarge Cap

Next catalyst

PDUFANov 27, 2026in 31 days

Neladalkib (NVL-655)

TKI pre-treated advanced ALK-positive NSCLC

FDA decision pageSource

Get an email about GSK's next catalysts

Track GSK (GSK) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 16 more upcoming events in our data (earnings, Phase 2 readout, Phase 3 readout and more).See the timeline

Catalyst Timeline

18 upcoming, 3 past

Earnings

GSK Earnings Report

Oct 28, 2026

EPS Est: $1.40 | FQ end Sep/2026 | Call: bmo

Phase 2

Belantamab Mafodotin-Blmf Phase 2 Est. Readout

October 2026~Belantamab Mafodotin-Blmf36

Estimated primary completion for Belantamab Mafodotin-Blmf trial (NCT05573802) in Multiple Myeloma. Topline data typically follows completion by weeks to months.

Source
Phase 2
✓Positive

Belantamab mafodotin Phase 2 Est. Readout

November 2026~Belantamab mafodotin41

Estimated primary completion for Belantamab mafodotin trial (NCT04680468) in Myeloma. Topline data typically follows completion by weeks to months.

Over 90% of patients responded to belantamab mafodotin plus daratumumab, lenalidomide, and dexamethasone (Bela-DRd) in the phase 1/2 study, with high MRD negativity rates reported in NDMM.

Source
Phase 2

Dostarlimab Phase 2 Est. Readout

November 2026~Dostarlimab25

Estimated primary completion for Dostarlimab trial (NCT05526989) in Penile Carcinoma. Topline data typically follows completion by weeks to months.

Source
Phase 2

Dostarlimab Phase 2 Est. Readout

November 2026~Dostarlimab120

Primary completion for Dostarlimab trial (NCT05723562) in Neoplasms, Rectal

Source
PDUFANext

FDA PDUFA Date neladalkib (NVL-655)

Nov 27, 2026Neladalkib (NVL-655)

For TKI pre-treated advanced ALK-positive NSCLC. NDA, Priority Review. Verified against the company announcement on 2026-10-16.

Source
Phase 2

Niraparib Phase 2 Est. Readout

Q4 2026~QNiraparib30

Primary completion for Niraparib trial (NCT04641247) in Ovarian Neoplasms

Source
Phase 2

MMB Phase 2 Est. Readout

Q4 2026~QMMB237

Primary completion for MMB trial (NCT03441113) in Neoplasms

Source

Upcoming FDA decisions

How GSK's past catalysts played out

PDUFA decisionJun 2019+3%

Market Overview

Stock performance and key metrics

NYSEPharmaceutical PreparationsPharmaceuticals🇺🇸EuropeLONDON65.0K employees

GSK plc (an abbreviation of its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.

Website
Drug Pipeline

GSK1120212

Phase 3

Cancer

GW685698/GW642444 (fluticasone furoate/vilanterol trifenatate)

Phase 3

Asthma

H5N1 adjuvanted split virus vaccine (A/Vietnam/1194/2004 strain)

Phase 3

Influenza

Depemokimab

Phase 3

Pulmonary Disease, Chronic Obstructive

Cervarix

Phase 3

Human Papillomavirus (HPV) Infection

GSK573719 62.5

Phase 3

Pulmonary Disease, Chronic Obstructive

Zalcitabine

Phase 3

HIV Infections

Pneumococcal (vaccine)

Phase 3

Acellular Pertussis

GSK investigational vaccine GSK2340272A

Phase 3

Influenza

SB213503 lot 1

Phase 3

Tetanus

Combined Hepatitis A and B vaccine

Phase 3

Hepatitis B

GSK1325760A

Phase 3

Pulmonary Arterial Hypertension

Thiomersal free trivalent influenza split vaccine 2003/2004

Phase 3

Influenza

GSK Biological's investigational MMRV vaccine 208136

Phase 3

Varicella

Havrix™ Junior

Phase 3

Influenza

Casopitant (GW679769) oral tablets

Phase 3

Vomiting

Infanrix/Hib™ vaccine

Phase 3

Malaria

GSK Biologicals' Meningococcal vaccine GSK134612 (Nimenrix)

Phase 3

Infections, Meningococcal

Netivudine

Phase 3

HIV Infections

Engerix™-B

Phase 3

Hepatitis B

GW685698X Aqueous Nasal Spray

Phase 3

Rhinitis, Allergic, Seasonal

Efimosfermin alfa

Phase 3

Non-alcoholic Fatty Liver Disease

Lyophilized mepolizumab

Phase 3

Asthma

FF/VI

Phase 3

Pulmonary Disease, Chronic Obstructive

Priorix™

Phase 3

Varicella

Danazol

Phase 3

Primary Myelofibrosis

Abacavir sulfate

Phase 3

HIV Infections

Depemokimab (GSK3511294)

Phase 3

Nasal Polyps

FSC

Phase 3

Pulmonary Disease, Chronic Obstructive

Mepolizumab 100 milligrams

Phase 3

Asthma

Botulinum Toxin Type A

Phase 3

Glabellar Lines

Lamivudine

Phase 3

HIV Infections

Pentamidine isethionate

Phase 3

Pneumonia, Pneumocystis Carinii

Fluviral®

Phase 3

Influenza

HRV Liquid

Phase 3

Rotavirus

Lamivudine/Zidovudine

Phase 3

HIV Infections

Zidovudine

Phase 3

HIV Infections

Atovaquone

Phase 3

Pneumonia, Pneumocystis Carinii

GSK573719 125

Phase 3

Pulmonary Disease, Chronic Obstructive

albiglutide

Phase 3

Diabetes Mellitus, Type 2

Amprenavir

Phase 3

HIV Infections

GW642444 25

Phase 3

Pulmonary Disease, Chronic Obstructive

Haemophilus influenzae type b- and meningococcal (vaccine)

Phase 3

Haemophilus Influenzae Type b

Gepotidacin

Phase 3

Infections, Bacterial

GSK573719/GW642444 125/25

Phase 3

Pulmonary Disease, Chronic Obstructive

Pneumococcal conjugate vaccine GSK1024850A

Phase 3

Infections, Streptococcal

Liquid formulation of HRV vaccine

Phase 3

Infections, Rotavirus

NaF

Phase 3

Caries

Tritanrix-HepB

Phase 3

Infections, Streptococcal

Indinavir sulfate

Phase 3

HIV Infections

Polio Sabin

Phase 3

Infections, Streptococcal

Mencevax-ACWY

Phase 3

Whole Cell Pertussis

FLU vaccine

Phase 3

Respiratory Syncytial Virus Infections

GSK1278863

Phase 3

Anaemia

Active OCS capsules (prednisolone or prednisone)

Phase 3

Hypereosinophilic Syndrome

Levocetirizine

Phase 3

Rhinitis

Ropinirole XL (formerly CR)

Phase 3

Parkinson Disease

Engerix-B™ vaccine

Phase 3

Malaria

Polio Sabin™ vaccine

Phase 3

Malaria

GSK1358820

Phase 3

Urinary Bladder, Overactive

Synflorix™ vaccine

Phase 3

Malaria

FF/GW642444 Inhalation Powder

Phase 3

Pulmonary Disease, Chronic Obstructive

Influenza vaccine GSK1562902A Formulation 1

Phase 3

Influenza

GSK investigational vaccine GSK1557482A

Phase 3

Influenza

HPV-16/1 VLP AS04

Phase 3

Infections, Papillomavirus

Synflorix™

Phase 3

Infections, Streptococcal

Casopitant

Phase 3

Nausea and Vomiting, Chemotherapy-Induced

fondaparinux

Phase 3

Fibrillation, Atrial

Rotarix™ vaccine

Phase 3

Malaria

ropinirole PR/XR

Phase 3

Parkinson Disease

Measles vaccine

Phase 3

Malaria

Cervarix™ (HPV-16/1 VLP AS04)

Phase 3

Infections, Papillomavirus

Neladalkib (NVL-655)

Phase 3

Non-small Cell Lung Cancer

Mencevax™ ACWY

Phase 3

Infections, Meningococcal

Standard therapy (Including Immunosuppressants)

Phase 3

Systemic Lupus Erythematosus

GSK Biologicals' combined diphtheria, tetanus, acellular pertussis vaccine

Phase 3

Diphtheria

GSK5784283

Phase 3

Asthma

Fluarix/Influsplit SSW 2012-2013

Phase 3

Influenza

FLU-QIV

Phase 3

Respiratory Syncytial Virus Infections

GSK Biologicals' HPV vaccine 580299

Phase 3

Infections, Papillomavirus

Rotarix

Phase 3

Infections, Rotavirus

Influsplit Tetra™ vaccine produced by investigational process (IP)

Phase 3

Influenza

2-dose oral live attenuated G1P[8] human rotavirus vaccine

Phase 3

Infections, Rotavirus

Subjects received 3 doses of GSK Biologicals' HPV vaccine (580299) (Cervarix™)

Phase 3

Infections, Papillomavirus

lamotrigine

Phase 3

Schizophrenia

paroxetine

Phase 3

Social Anxiety Disorder

Retosiban

Phase 3

Obstetric Labour, Premature

Ezogabine: USAN Retigabine (International Nonproprietary Name)

Phase 3

Epilepsy

MMRV

Phase 3

Rubella

Live attenuated human rotavirus vaccine

Phase 3

Rotavirus Gastroenteritis

paracetamol + caffeine

Phase 3

Common Cold

Twinrix™ adult

Phase 3

Hepatitis B

DTPw-HBV/Hib Kft vaccine GSK323527A

Phase 3

Hepatitis B

FF/VI via ELLIPTA DPI

Phase 3

Asthma

GW642444 Inhalation Powder

Phase 3

Pulmonary Disease, Chronic Obstructive

Influsplit™ Tetra (Fluarix™ Tetra)

Phase 3

Influenza

Rosiglitazone

Phase 3

Diabetes Mellitus, Type 2

Synflorix

Phase 3

Infections, Streptococcal

RSVPreF3 OA vaccine

Phase 3

Respiratory Syncytial Virus Infections

HZ/su vaccine

Phase 3

Respiratory Syncytial Viruses

Losmapimod

Phase 3

Glomerulosclerosis, Focal Segmental

GSK573719

Phase 3

Pulmonary Disease, Chronic Obstructive

PCV-free liquid formulation of GSK's oral live attenuated HRV vaccine

Phase 3

Infections, Rotavirus

VI

Phase 3

Pulmonary Disease, Chronic Obstructive

GSK573719/GW642444 62.5/25

Phase 3

Pulmonary Disease, Chronic Obstructive

Fluarix

Phase 3

Influenza

Boostrix™

Phase 3

Diphtheria

diclofenac sodium plus menthol

Phase 3

Pain

GSK580299 (Cervarix)

Phase 3

Infections, Papillomavirus

Meningococcal vaccine GSK 134612

Phase 3

Meningococcal Infection

mepolizumab

Phase 3

Hypereosinophilia

FF

Phase 3

Rhinitis, Allergic, Perennial

Cervarix™

Phase 3

Infections, Papillomavirus

GSK investigational FluNG vaccine GSK2186877A, aged lot

Phase 3

Influenza

DTPw-HBV/Hib-MenAC conjugate vaccine

Phase 3

Diphtheria

Tiotropium

Phase 3

Pulmonary Disease, Chronic Obstructive

Intravenous (IV) zanamivir

Phase 3

Influenza, Human

GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine

Phase 3

Haemophilus Influenzae Type b

Pediarix

Phase 3

Poliomyelitis

Measles, Mumps, Rubella and Chickenpox (live vaccine)

Phase 3

Measles

LEXIVA (GW433908)

Phase 3

HIV Infection

GSK Biologicals' liquid human rotavirus vaccine 444563

Phase 3

Infections, Rotavirus

stannous fluoride

Phase 3

Dentin Sensitivity

mometasone furoate

Phase 3

Rhinitis, Allergic, Perennial

PriorixTetra™

Phase 3

Rubella

Mepolizumab IV

Phase 3

Asthma

Fluarix Quadrivalent

Phase 3

Influenza

Influenza vaccine GSK2321138A

Phase 3

Influenza

mRNA-1273

Phase 3

Herpes Zoster

HSV vaccine or SB208141, GSK Biologicals' glycoprotein D (gD)-Alum/3-deacylated form of Monophosphoryl Lipid A (MPL) candidate genital herpes vaccine

Phase 3

Herpes Simplex Infection

FF/UMEC/VI

Phase 3

Asthma

HRV PCV-free liquid vaccine

Phase 3

Infections, Rotavirus

GSK investigational vaccine 2186877A

Phase 3

Influenza

Infanrix Hexa

Phase 3

Acellular Pertussis

Herpes Zoster Vaccine GSK1437173A

Phase 3

Herpes Zoster

Cobolimab

Phase 3

Melanoma

Dostarlimab

Phase 3

Neoplasms, Rectal

PoliorixTM

Phase 3

Poliomyelitis

Umeclidinium bromide

Phase 3

Pulmonary Disease, Chronic Obstructive

Malaria Vaccine 257049

Phase 3

Malaria

GSK580299, GSK Biological's HPV vaccine

Phase 3

Infections, Papillomavirus

Havrix®

Phase 3

Hepatitis A

HZ/su vaccine GSK1437173A

Phase 3

Herpes Zoster

BW430C (lamotrigine)

Phase 3

Bipolar Disorder

RSVPreF3 OA investigational vaccine

Phase 3

Respiratory Syncytial Virus Infections

Priorix®

Phase 3

Rubella

Daprodustat

Phase 3

Anaemia

Nitrofurantoin

Phase 3

Urinary Tract Infections

66 (Bupropion Hydrochloride Sustained Release)

Phase 3

Depressive Disorder

HZ/su

Phase 3

Herpes Zoster

Lovaza (omega-3-acid ethyl esters) plus atorvastatin

Phase 3

Hypertriglyceridemia

GSK573719/GW642444

Phase 3

Pulmonary Disease, Chronic Obstructive

human papillomavirus 1 virus-like particle/AS04 vaccine

Phase 3

Cervical Cancer

Ropinirole

Phase 3

Restless Legs Syndrome

Engerix™-B (thiomersal-free)

Phase 3

Hepatitis B

nicotine

Phase 3

Smoking Cessation

Mencevax™ACWY

Phase 3

Infections, Meningococcal

Adacel

Phase 3

Acellular Pertussis

Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (A/Indonesia)

Phase 3

Influenza

Meningitec™

Phase 3

Infections, Meningococcal

GSK Bio's influenza vaccine GSK2186877A

Phase 3

Influenza

Investigational varicella vaccine

Phase 3

Chickenpox

Itraconazole

Phase 3

Onychomycosis

valaciclovir HCl granules

Phase 3

Varicella

alitretinoin

Phase 3

Eczema

Mencevax ACWY

Phase 3

Infections, Meningococcal

GW406381

Phase 3

Arthritis, Rheumatoid

Prophylaxis: Diphtheria, tetanus and pertussis

Phase 3

Acellular Pertussis

rosiglitazone/metformin

Phase 3

Diabetes Mellitus, Type 2

CTGel/BPO Wash

Phase 3

Acne Vulgaris

Extended-release Bupropion Hydrochloride

Phase 3

Major Depressive Disorder (MDD)

SOC

Phase 3

Asthma

Abciximab

Phase 3

Infarction, Myocardial

CAPEOX

Phase 3

Colonic Neoplasms

HBV-MPL vaccine

Phase 3

Hepatitis B

Bexsero (GSK Biologicals' Meningococcal group-B vaccine/rMenB+OMV NZ)

Phase 3

Infections, Meningococcal

Tritanrix-HepB/Hib-MenAC

Phase 3

Whole Cell Pertussis

62.5/25mcg

Phase 3

Pulmonary Disease, Chronic Obstructive

GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations)

Phase 3

Influenza

GSK523338

Phase 3

Diabetes Mellitus, Type 2

Momelotinib

Phase 3

Primary Myelofibrosis

HBV-MPL 208129

Phase 3

Hepatitis B

GW815SF HFA MDI

Phase 3

Bronchial Asthma

GSK1605786A

Phase 3

Crohn's Disease

GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A)

Phase 3

Herpes Zoster

Vilanterol

Phase 3

Asthma

Ropinirole prolonged release

Phase 3

Parkinson Disease

Chemotherapy

Phase 3

Melanoma

Belantamab mafodotin

Phase 3

Multiple Myeloma

Liarozole

Phase 3

Ichthyosis, Lamellar

Lapatinib

Phase 3

Metastatic Breast Cancer

Influenza vaccine GSK2340272A

Phase 3

Influenza

Sodium Monofluorophosphate

Phase 3

Dentine Hypersensitivity

Meningococcal vaccine GSK134612

Phase 3

Infections, Meningococcal

NC-503 (Anti-amyloidotic (AA) Agent)

Phase 3

Secondary (AA) Amyloidosis

10 valent pneumococcal conjugate vaccine

Phase 3

Infections, Rotavirus

Infanrix-IPV+Hib™

Phase 3

Acellular Pertussis

Oral Casopitant (GW679769)

Phase 3

Nausea and Vomiting, Chemotherapy-Induced

UMEC/VI Inhalation Powder via NDPI

Phase 3

Pulmonary Disease, Chronic Obstructive

HBV-MPL vaccine 208129

Phase 3

Hepatitis B

clindamycin/benzoyl peroxide gel

Phase 3

Acne Vulgaris

Tritanrix-HepB/Meningitec conjugate vaccine

Phase 3

Diphtheria

Avandia

Phase 3

Insulin Resistance

Quadrivalent seasonal influenza vaccine(Flu D-QIV) GSK2321138A

Phase 3

Influenza

Lamictal

Phase 3

Epilepsy

Tenofovir disoproxil fumarate (TDF) tablets

Phase 3

Hepatitis B

Umeclidinium

Phase 3

Hyperhidrosis

FluLaval™ Quadrivalent

Phase 3

Influenza

GSK 573719 +GW642444 125/25

Phase 3

Pulmonary Disease, Chronic Obstructive

Rosiglitazone (BRL49653C)

Phase 3

Diabetes Mellitus, Type 2

diphtheria, tetanus, pertussis & Hib vaccine

Phase 3

Tetanus

GSK1562902A

Phase 3

Influenza

Priorix

Phase 3

Measles; Mumps; Rubella

Daprodustat small

Phase 3

Anaemia

Paracetamol SR

Phase 3

Pain

GSK3511294 (Depemokimab)

Phase 3

Asthma

fondaparinux - UFH not indicated

Phase 3

Thromboembolism

U0267

Phase 3

Psoriasis

Fluticasone Furoate/Vilanterol

Phase 3

Pulmonary Disease, Chronic Obstructive

Calcipotriene Foam

Phase 3

Psoriasis

glyburide

Phase 3

Diabetes Mellitus, Type 2

Standard therapy

Phase 3

Acute Coronary Syndrome

HZ/su vaccine (GSK1437173A)

Phase 3

Herpes Zoster

Belrestotug

Phase 3

Neoplasms, Head and Neck

GlaxoSmithKline (GSK) Biologicals' candidate Plasmodium falciparum malaria vaccine 257049

Phase 3

Malaria

carvedilol controlled release/lisinopril

Phase 3

Hypertension

MeMuRu-OKA (study vaccine)

Phase 3

Measles

Fluarix Tetra

Phase 3

Influenza

Valacyclovir hydrochloride

Phase 3

Cytomegalovirus Infections

Primaquine

Phase 3

Pneumonia, Pneumocystis Carinii

Hiberix™

Phase 3

Infections, Meningococcal

Paroxetine CR

Phase 3

Depressive Disorder, Major

sodium fluoride

Phase 3

Enamel Erosion

GSK investigational vaccine GSK2340269A

Phase 3

Influenza

BLU-5937

Phase 3

Cough

Cetirizine Dry Syrup

Phase 3

Pruritus

GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined 792014

Phase 3

Haemophilus Influenzae Type b

DTPa-HBV-IPV/Hib (Infanrix hexa™)

Phase 3

Hepatitis B

Tazarotene foam

Phase 3

Acne Vulgaris

CT Gel

Phase 3

Acne Vulgaris

UMEC/VI

Phase 3

Pulmonary Disease, Chronic Obstructive

Sumatriptan

Phase 3

Migraine Disorders

GW685698X

Phase 3

Asthma

GW572016 (Lapatinib)

Phase 3

Neoplasms, Breast

COVID-19 mRNA vaccine

Phase 3

Respiratory Syncytial Virus Infections

Gabapentin

Phase 3

Seizures

Sulfamethoxazole-Trimethoprim

Phase 3

Pneumonia, Pneumocystis Carinii

Henogen HBV vaccine

Phase 3

Hepatitis B

Havrix™

Phase 3

Hepatitis A

sodium fluoride and KNO3

Phase 3

Tooth Erosion

Best Available Therapy (BAT)

Phase 3

Primary Myelofibrosis (PMF)

Botulinum toxin A (GSK1358820)

Phase 3

Spasticity, Post-Stroke

Haemophilus influenzae type b and meningococcal serogroup C (vaccine)

Phase 3

Haemophilus Influenzae Type b

Retpamulin

Phase 3

Skin Infections, Bacterial

Simvastatin + Lovaza® (omega-3-acid ethyl esters)

Phase 3

Hypertriglyceridemia

Sulfonylurea

Phase 3

Diabetes Mellitus

Dutasteride

Phase 3

Alopecia

Combined diphtheria, tetanus, acellular pertussis vaccine

Phase 3

Diphtheria

Linerixibat

Phase 3

Pruritus

Finasteride active

Phase 3

Androgenetic Alopecia

PCV20

Phase 3

Respiratory Syncytial Virus Infections

U0267 Foam

Phase 3

Psoriasis

GSK Biologicals' candidate Plasmodium falciparum malaria vaccine (257049)

Phase 3

Malaria

fluticasone furoate

Phase 3

Hayfever

LAMICTAL extended-release

Phase 3

Epilepsy

AAPA

Phase 3

Chronic Hepatitis B

fluticasone propionate inhalation solution

Phase 3

Asthma

GSK573719/GW642444 Inhalation Powder

Phase 3

Pulmonary Disease, Chronic Obstructive

Combination Tablet of Treximet (sumatriptan/naproxen sodium)

Phase 3

Migraine Disorders

Influenza vaccine (A/H3N2, A/H1N1, and B strains)

Phase 3

Influenza

GSK Biologicals Influenza Vaccine GSK576389A

Phase 3

Influenza

alosetron

Phase 3

Irritable Colon

Clindamycin

Phase 3

Pneumonia, Pneumocystis Carinii

Dolutegravir/abacavir/lamivudine FDC

Phase 3

Infection, Human Immunodeficiency Virus

SB-275833

Phase 3

Impetigo

PAAA

Phase 3

Chronic Hepatitis B

Rotarix (primary vaccination study)

Phase 3

Infections, Rotavirus

Twinrix ™ Paediatric

Phase 3

Infections, Papillomavirus

Dapsone

Phase 3

Pneumonia, Pneumocystis Carinii

Tritanrix™- HepB

Phase 3

Infections, Meningococcal

darapladib

Phase 3

Retinopathy, Diabetic

Cervarix®

Phase 3

Infections, Meningococcal

raxibacumab

Phase 3

Healthy

Herpes Zoster vaccine GSK 1437173A

Phase 3

Herpes Zoster

Boostrix®

Phase 3

Infections, Meningococcal

denosumab

Phase 3

Osteoporosis, Postmenopausal

tablets of GSK1278863

Phase 3

Anaemia

rMenB+OMV NZ vaccine

Phase 3

Meningitis

GSK Biologicals HPV 16/18 vaccine 580299 (CervarixTM)

Phase 3

Infections, Papillomavirus

Influenza vaccine GSK2186877A

Phase 3

Influenza

Fluoride

Phase 3

Dental Caries

Hib-MenAC mixed with Tritanrix™-HepB

Phase 3

Tetanus

Niraparib

Phase 3

Ovarian Neoplasms

MenitorixTM

Phase 3

Neisseria Meningitidis

Boostrix

Phase 3

Tetanus

ferrous ascorbate

Phase 3

Haematopoiesis

Infanrix-IPV/Hib

Phase 3

Diphtheria

AAAA

Phase 3

Chronic Hepatitis B

Lamivudine plus Polyethylene glyco-interferon alfa-2b

Phase 3

Chronic Hepatitis B

Sodium Fluoride Toothpaste

Phase 3

Caries

Infanrix+Hib™

Phase 3

Acellular Pertussis

GSK3511294

Phase 3

Asthma

GW679769 (casopitant)

Phase 3

Nausea and Vomiting, Postoperative

Fluviral influenza vaccine, 2009-2010

Phase 3

Influenza

sumatriptan succinate/naproxen sodium

Phase 3

Migraine

NicVAX vaccine

Phase 3

Smoking Cessation

Retigabine IR

Phase 3

Epilepsy

Umeclidinium/vilanterol

Phase 3

Pulmonary Disease, Chronic Obstructive

Insulin Glargine and Insulin Lispro

Phase 3

Diabetes Mellitus, Type 2

Herpes simplex candidate vaccine- adjuvanted GSK 208141

Phase 3

Prophylaxis for Herpes Simplex

Sumatriptan and Naproxen Sodium

Phase 3

Migraine Disorders

Fondaparinux sodium

Phase 3

Embolism, Pulmonary

Recombinant MPL- adjuvanted hepatitis B vaccine

Phase 3

Hepatitis B

ropinirole controlled-release (REQUIP CR) for RLS

Phase 3

Parkinson's Disease

Cervarix TM

Phase 3

Infections, Papillomavirus

fosamprenavir

Phase 3

HIV Infections

Nicotine Spray

Phase 3

Tobacco Dependence

GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108)

Phase 3

Haemophilus Influenzae Type b

ropinirole Extended Release (XR)

Phase 3

Restless Legs Syndrome

dolutegravir OAD

Phase 3

Infection, Human Immunodeficiency Virus

Lyophilized formulation of HRV vaccine

Phase 3

Infections, Rotavirus

Hiberix

Phase 3

Infections, Streptococcal

Pneumococcal vaccine GSK1024850A

Phase 3

Infections, Streptococcal

HPV-16/1/AS04

Phase 3

Infections, Papillomavirus

Otelixizumab

Phase 3

Diabetes Mellitus, Type 1

Poliorix

Phase 3

Infections, Streptococcal

Tritanrix-HepB/Hiberix

Phase 3

Whole Cell Pertussis

Quadrivalent influenza GSK2282512A vaccine

Phase 3

Influenza

Experimental Denture Adhesive

Phase 3

Denture Retention

GSK Biologicals' quadrivalent seasonal influenza vaccine FLU-D-QIV GSK2321138A

Phase 3

Herpes Zoster

lamotrigine extended-release

Phase 3

Epilepsy

Influenza vaccine GSK1562902A Formulation 2

Phase 3

Influenza

DTPa-HBV-IPV/Hib

Phase 3

Haemophilus Influenzae Type b

Dose 1 GSK2586881

Phase 2

Lung Injury, Acute

GSK2269557 DPI

Phase 2

Pulmonary Disease, Chronic Obstructive

RTS,S/AS01E

Phase 2

Malaria

SB-485232

Phase 2

Melanoma

Investigational MMRV(H)NS vaccine

Phase 2

Measles; Mumps; Rubella; Chickenpox

RPT904

Phase 2

Ig-E Mediated Food Allergy

16448

Phase 2

Premature Ejaculation

1278863A

Phase 2

Kidney Disease

GBS Trivalent Vaccine

Phase 2

Bacterial Infection Due to Streptococcus, Group B

GSK malaria vaccine 257049 Vaccine

Phase 2

Malaria

GW869682

Phase 2

Obesity

A/turkey H5N1 vaccine

Phase 2

Influenza

GSK364735

Phase 2

Infection, Human Immunodeficiency Virus

Feladilimab

Phase 2

Multiple Myeloma

SB424323

Phase 2

Fibrillation, Atrial

GSK233705B

Phase 2

Pulmonary Disease, Chronic Obstructive

GSK835726

Phase 2

Rhinitis, Allergic, Seasonal

MenHibrix (Hib-MenCY-TT)

Phase 2

Neisseria Meningitidis

Varilrix (inactivated varicella vaccine)

Phase 2

Varicella

GW876008

Phase 2

Irritable Colon

Conjugated meningococcal ACWY-TT (vaccine)

Phase 2

Infections, Meningococcal

GSK256073

Phase 2

Diabetes Mellitus, Type 2

GSK2190915

Phase 2

Asthma

Ofatumumab

Phase 2

Lymphoma, Large-Cell, Diffuse

GSK2402968

Phase 2

Muscular Dystrophies

Priorix-Tetra (combined measles-mumps-rubella-varicella vaccine)

Phase 2

Measles

GlaxoSmithKline (GSK) Biologicals' investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (ChAd3-EBO-Z) (GSK3390107A)

Phase 2

Virus Diseases

Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab)

Phase 2

Lymphoma, Non-Hodgkin

Prevenar 13

Phase 2

Acellular Pertussis

GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049

Phase 2

Malaria

GSK2269557

Phase 2

Pulmonary Disease, Chronic Obstructive

Otilimab

Phase 2

Severe Acute Respiratory Syndrome

Paracetamol hot drink

Phase 2

Common Cold

Iodine I 131 Tositumomab

Phase 2

Non-Hodgkin's Lymphoma

GSK2202083A vaccine

Phase 2

Tetanus

GSK2894512

Phase 2

Psoriasis

Potassium nitrate and sodium fluoride

Phase 2

Dentin Sensitivity

Nucleos(t)ide therapy

Phase 2

Hepatitis B

GI198745

Phase 2

Benign Prostatic Hyperplasia

alvimopan

Phase 2

Constipation

Carbon Dioxide

Phase 2

Nasal Congestion

Immunotherapeutic GSK2132231A

Phase 2

Melanoma

FMP1/AS02A

Phase 2

Malaria, Falciparum

Standard fluoride dentifrice

Phase 2

Dentin Sensitivity

GSK Biologicals' Pandemic influenza (H1N1) candidate vaccine (GSK2340274A)

Phase 2

Influenza

GSK3389404

Phase 2

Hepatitis B

Lapatinib and Capecitabine

Phase 2

Neoplasms, Gastrointestinal Tract

SB-681323

Phase 2

Coronary Heart Disease

azelastine hydrochloride

Phase 2

Allergic Rhinitis

HBV-MPL vaccine (208129)

Phase 2

Hepatitis B

HIV vaccine 732461

Phase 2

AIDS

Sterile water

Phase 2

Tooth Erosion

Thiomersal-free FluAS25 adjuvanted vaccine (GSK576389A)

Phase 2

Influenza

GSK's candidate Mycobacterium tuberculosis vaccine 692342

Phase 2

Tuberculosis

GSK2036874A vaccine

Phase 2

Haemophilus Influenzae Type b

Infanrix hexa Vaccine

Phase 2

Acellular Pertussis

GW493838

Phase 2

Neuropathic Pain

Meningococcal vaccine 134612

Phase 2

Infections, Meningococcal

NTHi-10-AS01E

Phase 2

Respiratory Disorders

Menactra®

Phase 2

Infections, Meningococcal

Nicotine lower dose

Phase 2

Smoking

Adjuvanted RSVPreF3 vaccine

Phase 2

Respiratory Syncytial Virus Infections

FF/Vilanterol (VI; GW642444M)

Phase 2

Asthma

GSK5460025

Phase 2

Neoplasms, Colorectal

RTS,S/AS01E (SB257049)

Phase 2

Malaria

GSK2336805

Phase 2

Hepatitis C, Chronic

GSK163090

Phase 2

Depressive Disorder

SB-480848

Phase 2

Atherosclerosis

SB497115

Phase 2

Purpura, Thrombocytopaenic, Idiopathic

adjuvanted influenza vaccine

Phase 2

Influenza

RSV vaccine GSK3003891A

Phase 2

Respiratory Syncytial Virus Infections

Human Rotavirus Vaccine - two different formulations

Phase 2

Infections, Rotavirus

Carbomer 980 (1146A)

Phase 2

Common Cold

GSK Biologicals' investigational TB vaccine (GSK692342)

Phase 2

Tuberculosis

RSVPreF3 OA investigational vaccine (GSK3844766A)

Phase 2

Respiratory Syncytial Virus Infections

Chloroquine

Phase 2

Malaria, Vivax

MenC-TT

Phase 2

Infections, Meningococcal

Pneumococcal vaccine GSK513026

Phase 2

Prophylaxis Invasive Pneumococcal Diseases and Pneumonia

FF/levocabastine

Phase 2

Rhinitis, Allergic, Perennial and Seasonal

GSK Biologicals' 208136, new formulation

Phase 2

Measles

Ispinesib

Phase 2

Neoplasms, Breast

MEDI 517

Phase 2

Healthy

Ofatumumab (This arm is closed)

Phase 2

Mantle Cell Lymphoma

levocabastine

Phase 2

Rhinitis, Allergic, Perennial and Seasonal

Belantamab Mafodotin-Blmf

Phase 2

Multiple Myeloma

GSK Biolgicals' meningococcal vaccine 134612 (Nimenrix)

Phase 2

Infections, Meningococcal

GW642444 (25, 100 &)

Phase 2

Pulmonary Disease, Chronic Obstructive

Zidesamtinib (NVL-520)

Phase 2

Locally Advanced Solid Tumor

GSK372475

Phase 2

Depressive Disorder

oral nicotine

Phase 2

Smoking Dependence

Rotavirus

Phase 2

Infections, Rotavirus

nelarabine

Phase 2

Leukemia

GSK2197870A

Phase 2

Neisseria Meningitidis

Lapatinib in combination with weekly paclitaxel

Phase 2

Neoplasms, Breast

GW685698X,GW685698X

Phase 2

Asthma

SB-773812

Phase 2

Schizophrenia

Tositumomab and Iodine I 131 Tositumomab

Phase 2

Lymphoma, Non-Hodgkin

683699

Phase 2

Crohn's Disease

Iodine I 131 Tositumomab Therapeutic Regimen

Phase 2

Lymphoma, Non-Hodgkin

Intravenous GR270773- Phospholipid Emulsion

Phase 2

Sepsis

GSK2110183

Phase 2

Langerhans Cell Histiocytosis

Prophylaxis: Diphtheria, tetanus, pertussis, poliovirus type 1, type 2 and type 3

Phase 2

Diphtheria

Herpes Zoster vaccine GSK1437173A Low Dose

Phase 2

Herpes Zoster

SRA737, gemcitabine, cisplatin

Phase 2

Advanced Solid Tumors

NC-758 (Anti amyloidotic [Aß] agent)

Phase 2

Stroke

GSK Biologicals' influenza vaccine GSK1557482A

Phase 2

Influenza

SB-705498

Phase 2

Rhinitis

GW823093

Phase 2

Diabetes Mellitus, Type 2

GSK573179

Phase 2

Pulmonary Disease, Chronic Obstructive

Talarozole

Phase 2

Psoriasis

Non-adjuvanted HSV formulation 1

Phase 2

Herpes Simplex

PNT2258

Phase 2

Lymphoma, Non-Hodgkin's

GSK256066

Phase 2

Asthma

GSK's investigational vaccine 692342

Phase 2

Tuberculosis

Albaconazole

Phase 2

Onychomycosis

GSK2881078

Phase 2

Cachexia

Tositumomab

Phase 2

Lymphoma, Non-Hodgkin

GSK962040 (tablet)

Phase 2

Gastroparesis

Benzoyl peroxide gel

Phase 2

Acne Vulgaris

MMB

Phase 2

Primary Myelofibrosis (PMF)

Zanamivir

Phase 2

Influenza, Human

NC-503 (eprodisate disodium)

Phase 2

Diabetes Mellitus, Type 2

GSK1363089 (foretinib)

Phase 2

Neoplasms, Head and Neck

SRT2104

Phase 2

Diabetes Mellitus, Type 2

SRA737

Phase 2

Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)

GSK189075

Phase 2

Diabetes Mellitus, Type 2

NTHi Mcat investigational vaccine (GSK3277511A)

Phase 2

Respiratory Disorders

CYT387

Phase 2

Primary Myelofibrosis

GSK249320

Phase 2

Ischaemic Attack, Transient

eltrombopag

Phase 2

Purpura, Thrombocytopaenic, Idiopathic

HPV 16/18 VLP AS04

Phase 2

Infections, Papillomavirus

GW274150

Phase 2

Migraine Disorders

SB-681323 Intravenous

Phase 2

Lung Injury, Acute

GSK239512

Phase 2

Schizophrenia

foretinib (formerly GSK1363089 or XL880)

Phase 2

Carcinoma, Renal Cell

GS856553

Phase 2

Pain, Neuropathic

albiglutide (GSK716155)

Phase 2

Diabetes Mellitus, Type 2

GSK4527226

Phase 2

Alzheimer's Disease

Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose

Phase 2

Salmonella Infections

Aprepitant

Phase 2

Nausea and Vomiting

atorvastatin

Phase 2

Dyslipidaemias

KNO3/NaF dentifrice with spherical silica

Phase 2

Oral Hygiene

salmeterol

Phase 2

Asthma

F2C22C/DL001Z

Phase 2

Influenza, Human

rhEPO

Phase 2

Anaemia

Chlorproguanil-dapsone-artesunate (CDA)

Phase 2

Malaria

GSK2798745 solution

Phase 2

Oedema, Pulmonary

meningococcal ACWY (vaccine)

Phase 2

Infections, Meningococcal

Nirogacestat

Phase 2

Multiple Myeloma

FP

Phase 2

Rhinitis

Adjuvanted Hepatitis B surface antigen (HBsAg) candidate vaccine GSK2231392A

Phase 2

Hepatitis B

GW856553

Phase 2

Arthritis, Rheumatoid

Influenza Vaccine GSK1247446A

Phase 2

Influenza

tositumomab and iodine I-131 tositumomab

Phase 2

Lymphoma, Non-Hodgkin

Live attenuated rotavirus vaccine

Phase 2

Infections, Rotavirus

Adjuvanted herpes simplex (gD) candidate vaccine GSK 208141

Phase 2

Prophylaxis Herpes Simplex

letetresgene autoleucel (GSK3377794)

Phase 2

Neoplasms

GSK4524101

Phase 2

Neoplasms

GW842166

Phase 2

Osteoarthritis, Knee

pazopanib (GW786034)

Phase 2

Neoplasms, Uterine Cervix

GW642444

Phase 2

Pulmonary Disease, Chronic Obstructive

GSK4532990

Phase 2

Non-alcoholic Fatty Liver Disease

Pneumococcal vaccine GSK2189242A

Phase 2

Infections, Streptococcal

Losmapimod tablets

Phase 2

Pulmonary Disease, Chronic Obstructive

DTPa-HBV-IPV/Hib (Infanrix-hexa™)

Phase 2

Hepatitis B

Lapatinib oral tablets

Phase 2

Neoplasms, Breast

GSK3228836

Phase 2

Hepatitis B

RTS,S/AS01E vaccine

Phase 2

Malaria

Nelfinavir mesylate

Phase 2

HIV Infections

SB683699

Phase 2

Multiple Sclerosis, Relapsing-Remitting

Stavudine

Phase 2

HIV Infections

Ritonavir

Phase 2

HIV Infections

Firategrast

Phase 2

Multiple Sclerosis

Ambrisentan

Phase 2

Hypertension, Pulmonary

SB-742457

Phase 2

Alzheimer's Disease

GSK2245035

Phase 2

Asthma and Rhinitis

Rotavirus (vaccine)

Phase 2

Rotavirus Infections

GW870086X

Phase 2

Asthma

Efavirenz

Phase 2

HIV Infections

Radafaxine

Phase 2

Major Depressive Disorder (MDD)

IONIS-HBVRx

Phase 2

Hepatitis B

RTS,S/AS02A

Phase 2

Malaria

HRV vaccine

Phase 2

Infections, Rotavirus

GW501516 oral tablets

Phase 2

Dyslipidaemias

GSK Biologicals' Candidate Tuberculosis (TB) Vaccine (692342)

Phase 2

Tuberculosis (TB)

CV0701 mRNA COVID-19 Vaccine (Low dose)

Phase 2

SARS-CoV-2

Flu Pandemic mRNA_Dose level 1

Phase 2

Influenza, Human

GW677954

Phase 2

Metabolic Syndrome X

GW786034

Phase 2

Carcinoma, Renal Cell

GSK3196165

Phase 2

Arthritis, Rheumatoid

SB681323

Phase 2

Pain, Neuropathic

RSV Vaccine (GSK3003891A) formulation 1

Phase 2

Respiratory Syncytial Virus Infections

Tritanrix™ HB+Hib

Phase 2

Tuberculosis

GW766944

Phase 2

Asthma

Sodium bicarbonate and sodium fluoride

Phase 2

Oral Hygiene

FLU-Q-PAN H7N9 Formulation 1

Phase 2

Influenza, Human

ropinirole controlled release (CR)-RLS

Phase 2

Restless Legs Syndrome

GSK1292263

Phase 2

Diabetes Mellitus, Type 2

Albiglutide (GSK716155) or exenatide

Phase 2

Diabetes Mellitus, Type 2

Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted

Phase 2

Influenza

pazopanib and pemetrexed

Phase 2

Lung Cancer, Non-Small Cell

GSK2118436

Phase 2

Melanoma and Brain Metastases

GSK Biologicals' HIV vaccine (732461)

Phase 2

AIDS

Mepolizumab 750

Phase 2

Asthma

HPV 1 AS04

Phase 2

Infections, Papillomavirus

Talnetant

Phase 2

Schizophrenia

Topotecan/Docetaxel combination

Phase 2

Lung Cancer, Non-Small Cell

SB705498

Phase 2

Toothache

FFNS

Phase 2

Sinusitis, Acute

Dose 4 QD

Phase 2

Asthma

Batefenterol

Phase 2

Pulmonary Disease, Chronic Obstructive

GSK Biologicals' investigational TB vaccine GSK 692342

Phase 2

Tuberculosis

Pandemic influenza vaccine GSK2340272A

Phase 2

Influenza

Meningococcal (vaccine)

Phase 2

Infections, Meningococcal

GW679769

Phase 2

Depressive Disorder, Major

Nanomilled testosterone

Phase 2

Hypogonadism

GSK2982772

Phase 2

Psoriasis

Pandemic influenza vaccine (GSK1562902A) (adjuvanted or not)

Phase 2

Influenza

GW810781

Phase 2

HIV Infections

vestipitant

Phase 2

Depressive Disorder and Anxiety Disorders

rosiglitazone XR

Phase 2

Arthritis, Rheumatoid

cycolophosphamide, vacristine, and pednisone (CVP) x6 cycles followed by tositumomab and iodine I 131 tositumomab

Phase 2

Lymphoma, Non-Hodgkin

Influenza A (H5N1) Virus monovalent vaccine (GSK1557484A)

Phase 2

Influenza

Bepirovirsen

Phase 2

Hepatitis B

GSK Biologicals' investigational vaccine GSK1562902A

Phase 2

Influenza

Pneumococcal vaccine GSK2189242A (formulation 1)

Phase 2

Infections, Streptococcal

Unconjugated belantamab antibody

Phase 2

Multiple Myeloma

vinorelbine tartrate

Phase 2

Lung Cancer

GSK2330672

Phase 2

Cholestasis, Intrahepatic

Candidate Influenza Vaccine GSK1247446A - 2 different formulations

Phase 2

Influenza

GW685698/GW642444

Phase 2

Pulmonary Disease, Chronic Obstructive

GSK Biologicals HIV Vaccine 732462

Phase 2

AIDS

GSK Biologicals' GSK2340274A (two different formulations)

Phase 2

Influenza

Luspatercept

Phase 2

Primary Myelofibrosis

GSK1521498

Phase 2

Obesity

PegIFN

Phase 2

Hepatitis B

Cervarix vaccine

Phase 2

Infections, Papillomavirus

GSK221149A

Phase 2

Obstetric Labour, Premature

GSK716155 subcutaneous injections

Phase 2

Diabetes Mellitus, Type 2

chlorambucil, tablets

Phase 2

Leukaemia, Lymphoblastic

RSV MAT

Phase 2

Respiratory Syncytial Virus Infections

chlorhexidine mouthrinse

Phase 2

Healthy Subjects

Run In Medication

Phase 2

Nasal Polyps

SB480848 EC

Phase 2

Atherosclerosis

retapamulin

Phase 2

Infections, Bacterial

SERETIDE Rotacaps

Phase 2

Asthma

UMEC

Phase 2

Asthma

GSK2340274A

Phase 2

Influenza

Flu mRNA (Formulation B1)

Phase 2

Influenza, Human

HPV9 High formulation

Phase 2

Cervical Intraepithelial Neoplasia

FP 100

Phase 2

Asthma

Tucaresol

Phase 2

HIV Infection

GSK962040

Phase 2

Gastroparesis

Midazolam

Phase 2

Locally Advanced Solid Tumor

Part A

Phase 2

Arthritis, Rheumatoid

Pre-transfection F17

Phase 2

Dengue

Tositumomab and Iodine I 131 Tositumomab (Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody)

Phase 2

Lymphoma, Non-Hodgkin

GI262570

Phase 2

Cirrhosis, Liver

GSK A/turkey H5N1 Influenza vaccine

Phase 2

Influenza

Tiotropium + SERETIDE 50/500

Phase 2

Pulmonary Disease, Chronic Obstructive

rilapladib

Phase 2

Alzheimer's Disease

eniluracil

Phase 2

Colorectal Cancer

epidoxorubicin

Phase 2

Neoplasms, Breast

Ranitidine hydrochloride

Phase 2

HIV Infections

Glycovir

Phase 2

HIV Infections

Interferon alfa-2a

Phase 2

HIV Infections

AltSonflex1-2-3 Low Dose

Phase 2

Diarrhoea

Topotecan, Filgrastim (G-CSF), Pegfilgrastim

Phase 2

Wilms Tumor

Hib-MenC-TT

Phase 2

Infections, Meningococcal

amodiaquine

Phase 2

Malaria

Investigational Cancer Drug

Phase 2

Metastatic Breast Cancer

MR-Vac

Phase 2

Diarrhoea

Falciparum Malaria Protein 11 with AS01B adjuvant

Phase 2

Plasmodium Falciparum Malaria

vestipitant/paroxetine

Phase 2

Social Phobia

AltSonflex1-2-3 High Dose

Phase 2

Diarrhoea

DEN

Phase 2

Diabetes Mellitus, Type 2

sulfadoxine-pyrimethamine

Phase 2

Malaria

KNO3/NaF dentifrice with spherical silica and STP

Phase 2

Oral Hygiene

GSK257049 Dosage 1

Phase 2

Malaria

Boostrix-ex-US

Phase 2

Respiratory Syncytial Virus Infections

GSK2340273A

Phase 2

Influenza

Paclitaxel infusion

Phase 2

Neoplasms, Breast

RSVPreF3 formulation 3

Phase 2

Respiratory Syncytial Virus Infections

AltSonflex1-2-3 Medium Dose

Phase 2

Diarrhoea

Boostrix-US

Phase 2

Respiratory Syncytial Virus Infections

GSK257049 Dosage 2

Phase 2

Malaria

lapatinib ditosylate

Phase 2

Prostate Cancer

RSVPreF3 formulation 2

Phase 2

Respiratory Syncytial Virus Infections

Interferon alfa-n1

Phase 2

HIV Infections

RIFAFOUR e-275

Phase 2

Tuberculosis

Prevnar™

Phase 2

Tuberculosis

SB656933

Phase 2

Cystic Fibrosis

GW679769 oral tablets

Phase 2

Nonulcer Dyspepsia

Chemotherapy, multiple agents

Phase 2

Ovarian Cancer

BMS-955176

Phase 2

Infection, Human Immunodeficiency Virus

Meningococcal vaccine GSK134612 (Nimenrix)

Phase 2

Infections, Meningococcal

HPV investigational vaccine GSK568893A, different formulations

Phase 2

Infections, Papillomavirus

Lovaza (omega-3-acid ethyl esters)

Phase 2

Muscle Damage

Pretomanid

Phase 2

Tuberculosis

FluLaval® Quadrivalent

Phase 2

Influenza

Polio Sabin™

Phase 2

Tuberculosis

GSK3036656

Phase 2

Tuberculosis

BTZ-043

Phase 2

Tuberculosis

Bedaquiline

Phase 2

Tuberculosis

Delamanid

Phase 2

Tuberculosis

Emtricitabine

Phase 2

Infection, Human Immunodeficiency Virus

Nimenrix

Phase 2

Infections, Meningococcal

Hepatitis B

3 drugs in this indication

cough

2 drugs in this indication

lung cancer

2 drugs in this indication

Pulmonary Disease, Chronic Obstructive

2 drugs in this indication

Acute Coronary Syndrome

1 drug in this indication

Malaria

1 drug in this indication

refractory chronic cough

1 drug in this indication

chronic cough

1 drug in this indication

dementia prevention

1 drug in this indication

chronic cough (RCC), IBS

1 drug in this indication

colorectal cancer, pancreatic cancer, lung cancer

1 drug in this indication

solid tumours

1 drug in this indication

shingles prevention

1 drug in this indication

NSCLC

1 drug in this indication

ROS1-positive lung cancer

1 drug in this indication

Prevention of diphtheria, tetanus, and pertussis

1 drug in this indication

Dental Caries

1 drug in this indication

ROS1-positive non-small cell lung cancer

1 drug in this indication

Newly diagnosed multiple myeloma (NDMM)

1 drug in this indication

cancer

1 drug in this indication

Chronic hepatitis B (functional cure)

1 drug in this indication

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

📑
Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
→

Frequently asked questions

What is in GSK plc's drug pipeline?→

CatalystAlert tracks 640 drug candidates in GSK plc's (GSK) pipeline across Phase 3, Phase 2. Its lead program is Neladalkib (NVL-655) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is GSK plc's next FDA catalyst?→

GSK plc's (GSK) next tracked catalyst is a PDUFA date expected Nov 27, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track GSK biotech catalysts?→

Add GSK to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow GSK plc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply